Ashigarakami-gun, Japan

Keiko Makita

USPTO Granted Patents = 2 


Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Ashigarakami-gun, JP (2021)
  • Kanagawa, JP (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiko Makita: Innovator in Fluorescent Compounds and Antitumor Agents

Introduction

Keiko Makita is a prominent inventor based in Ashigarakami-gun, Japan. She has made significant contributions to the field of chemistry, particularly in the development of fluorescent compounds and antitumor agents. With a total of two patents to her name, her work has the potential to impact various scientific and medical applications.

Latest Patents

Keiko Makita's latest patents include a fluorescent compound and a fluorescent labeled biological substance. These innovations provide a range of fluorescent compounds and biological substances that utilize these compounds. One of her notable inventions is an antitumor agent and bromodomain inhibitor. This invention aims to offer effective treatment options for tumors associated with bromodomains, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Keiko has worked with esteemed organizations such as Fujifilm Corporation and Fujifilm Toyama Chemical Co., Ltd. Her experience in these companies has allowed her to collaborate on various innovative projects, further enhancing her expertise in the field.

Collaborations

Keiko has collaborated with notable coworkers, including Hiyoku Nakata and Kousuke Watanabe. These partnerships have contributed to her success and the development of her groundbreaking inventions.

Conclusion

Keiko Makita is a trailblazer in the field of chemistry, with her patents reflecting her innovative spirit and dedication to improving medical treatments. Her work continues to inspire future advancements in science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…